Drug trials and AI have stocks moving this morning

Today’s big movers inside                                                                                                                                                                                                                                                                                                                                                                                                                 June 12, 2024 | [Read Online]( Drug trials and AI have stocks moving this morning Today’s big movers inside *together with TheoTrade Good day, 360! Here are our top investing ideas today. Please [join us for a special session]( geared towards newbie options traders TONIGHT at 7pm EST. Pass this invite along with our compliments! FOCUS LIST🔎 RNA - Up over 20% in the pre-market after Phase ½ FORTITUDE™ trial demonstrated greater than 50 percent reduction in DUX4 regulated genes and trends of functional improvement in people living with Facioscapulohumeral Muscular Dystrophy MICS - Up over 14% in pre after acquiring SemiCab, a leading AI logistics technology company ORCL - Up over 8% in pre after reporting better than expected earnings, AI fueled cloud growth *together with TheoTrade “Trade Outside of Normal”  See Jeff’s [interview]( with Senior Market Strategist, Blake Young of TheoTrade, and add some new tools to your trading toolbelt! If you dig THIS, register for Blake’s COMPLIMENTARY 113 Deep Currents Watch List this Thursday, June 13th @7pm EST. [Secure Your Spot!]( HOTLIST🔥 RNA - Up over 20% in the pre-market after Phase ½ FORTITUDE™ trial demonstrated greater than 50 percent reduction in DUX4 regulated genes and trends of functional improvement in people living with Facioscapulohumeral Muscular Dystrophy Avidity Biosciences Inc. (RNA) is a biopharmaceutical company that engages in the delivery of RNA therapeutics. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat diseases previously untreatable with RNA therapeutics. In the pre-market this morning the [company announced]( that its Phase ½ FORTITUDE™ trial demonstrated greater than 50 percent reduction in DUX4 regulated genes and trends of functional improvement in people living with Facioscapulohumeral Muscular Dystrophy. Avidity plans to accelerate the initiation of registrational cohorts in FORTITUDE™ trial Delpacibart braxlosiran (AOC 1020), the first investigational therapy to target the underlying cause of FSHD, provided greater than 50% mean reduction across multiple DUX4 regulated gene panels (2 mg/kg at four months) Trends of functional improvement including muscle strength, reachable workspace, and positive trends in patient and clinician reported outcomes demonstrated in people treated with delpacibart braxlosiran 2 mg/kg at four months Delpacibart braxlosiran data demonstrate favorable safety and tolerability with all adverse events mild or moderate The stock traded up over 19% in the pre-market in reaction to the news. The first target for bulls is the pre-market high at $38.25. Beyond that is all time highs and round number targets such as $40, $45 and $50 come into play. Below $38.25, targets to the downside are $36, $34.70, $33, $30 and then $28.92. MICS - Up over 14% in pre after acquiring SemiCab, a leading AI logistics technology company The Singing Machine Company Inc. (MICS) together with its subsidiaries, engages in the development, marketing, and sale of consumer karaoke audio equipment, accessories, and musical recordings in North America and internationally. In the pre-market this morning, the [company announced]( that it had acquired SemiCab, a leading AI logistics technology company. SemiCab optimizes freight for Fortune 1000 clients in the US and Indian markets. SemiCab’s AI technology was developed specifically to build a hyper-efficient trucking network that operates at a 90%+ utilization level, well above the industry standard of 65%. This technology connects thousands of parties on a single network, building fully optimized transit routes that drive costs efficiencies for both the customer and the shipper. MICS traded up over 14% in the pre-market in reaction to the news of the acquisition. The $1.98 area has acted as support and will be an important level to watch. Above it, targets to the upside are $2.10, $2.20, $2.30, $2.50 and then the pre-market high at $2.58. Beyond that $3, $3.50, $4, $4.50 and $5 come into play. Below $1.98, targets to the downside are $1.88 and $1.50. [MARKET NAVIGATOR]( Options trading doesn't have to be complicated. Let Jeff Williams teach you how to trade just ONE stock 👀 [BE HERE TONIGHT @ 7PM ET]( 🎁Special bonus for attendees 🎁 ORCL - Up over 8% in pre after reporting better than expected earnings, AI fueled cloud growth Oracle Corporation (ORCL) offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications. In the after-hours the [company reported]( Q4 and fill year earnings. Highlights include: Q4 Cloud Revenue (IaaS plus SaaS) $5.3 billion, up 20% in USD and constant currency Q4 Cloud Infrastructure (IaaS) Revenue $2.0 billion, up 42% in USD and constant currency Q4 Cloud Application (SaaS) Revenue $3.3 billion, up 10% in USD and constant currency The stock traded up over 8% in the pre-market in reaction to the results. The first target for bulls is the after-hours high at $137.33. Beyond that, is blue sky all-time highs and round numbers such as $140, $145 and $150 come into play. Below $137.33, targets to the downside are $136, $134, $132, $130, $128, $126 and then a gap fill at 123.88. CALENDAR 🗓️ P.S. Make sure you text “RAGE” to (888) 404-5747 to get all of our latest HOT STOCK ideas! Questions or concerns about our products? Email [Support@360wallstreet.io]( © Copyright 2022, RagingBull DISCLAIMER To more fully understand any Ragingbull.com, LLC ("RagingBull") subscription, website, application or other service ("Services"), please review our full disclaimer located at [( FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. Any RagingBull Service offered is for educational and informational purposes only and should NOT be construed as a securities-related offer or solicitation, or be relied upon as personalized investment advice. RagingBull strongly recommends you consult a licensed or registered professional before making any investment decision. *Sponsored content: We’re a proud affiliate for TheoTrade, meaning if you click a link for a product or service, we may earn a commission at no extra cost to you. We believe in the companies we form affiliate relationships with, but please don’t spend any money on these products or services unless you believe they will help you achieve your goals. RESULTS PRESENTED NOT TYPICAL OR VERIFIED. RagingBull Services may contain information regarding the historical trading performance of RagingBull owners or employees, and/or testimonials of non-employees depicting profitability that are believed to be true based on the representations of the persons voluntarily providing the testimonial. However, subscribers' trading results have NOT been tracked or verified and past performance is not necessarily indicative of future results, and the results presented in this communication are NOT TYPICAL. Actual results will vary widely given a variety of factors such as experience, skill, risk mitigation practices, market dynamics and the amount of capital deployed. Investing in securities is speculative and carries a high degree of risk; you may lose some, all, or possibly more than your original investment. RAGINGBULL IS NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. Neither RagingBull nor any of its owners or employees is registered as a securities broker-dealer, broker, investment advisor (IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization. Employees, owners, and other service providers of https:// ragingbull. com or RagingBull.com LLC are paid in whole or in part by commission based on their sales of Services to subscribers. RagingBull.com, LLC shall be entitled to recover attorneys’ fees, costs and disbursements. In the event that any suit or action is instituted as a result of doing business with RagingBull. com, LLC and/or its affiliates or if any suit or action is necessary to enforce or interpret these Terms of Service, RagingBull. com, LLC shall be entitled to recover attorneys’ fees, costs and disbursements in addition to any other relief to which it may be entitled. WE MAY HOLD SECURITIES DISCUSSED. RagingBull has not been paid directly or indirectly by the issuer of any security mentioned in the Services except possibly by advertisers in this email. However, Ragingbull.com, LLC, its owners, and its employees may purchase, sell, or hold long or short positions in securities of the companies mentioned in this communication. [tw]( Update your email preferences or unsubscribe [here]( © 2024 360 WallStreet 62 Calef Hwy. #233 lee, NH 03861, United States of America